Acurx Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Acurx Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
Acurx Pharmaceuticals, Inc. Assets for the quarter ending June 30, 2024 was $6.58M.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$6.58M			Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$9.11M			Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$7.71M	-$1.67M	-17.8%	Dec 31, 2023	10-Q	2024-08-08
Q4 2022	$9.38M	-$3.88M	-29.3%	Dec 31, 2022	10-K	2024-03-15
Q2 2022	$9.26M	-$8.18M	-46.9%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$11.3M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$13.3M	+$10M	+311%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$15M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$17.4M			Jun 30, 2021	10-Q	2021-08-13
Q4 2020	$3.22M			Dec 31, 2020	10-K	2022-03-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.